Cristina Di Giorgio

8PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPharmacogenomicsMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 19, 2026
A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.

Michele Biagioli, Cristina Di Giorgio, Silvia Marchianò

|Aug 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice.

Cristina Di Giorgio, Ginevra Urbani, Carmen Massa

|Jan 13, 2025
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- Mice.

Cristina Di Giorgio, Ginevra Urbani, Silvia Marchianò

|Oct 15, 2024
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments.

Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio

|Nov 24, 2023
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease.

Silvia Marchianò, Michele Biagioli, Martina Bordoni

|Nov 22, 2022
Modeling Inflammatory Bowel Disease by Intestinal Organoids.

Cristina Di Giorgio, Rosalinda Roselli, Michele Biagioli

Pageof 2

Frequent Collaborators

6 joint publications

Michele Biagioli

5 joint publications

Stefano Fiorucci

4 joint publications

Angela Zampella

3 joint publications

Elva Morretta